DSpace at RU >

Search Results

Results 1-50 of 428.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2011	The Tissue Origin and Culture History of Mesenchymal Stem Cells Affect their Performance in Osteoblastic Differentiation.	Berk, L.C.J. van den; Jansen, B.J.H.; Siebers-Vermeulen, K.G.C.; Huijsi, T.; Roelofs, H.; Kogler, G.; Figdor, C.G.; Torensma, R.
	2011	Eradicating cancer cells: struggle with a chameleon	Di, J.; Duiveman-de Boer, T.; Figdor, C.G.; Torensma, R.
	2011	The lymphoid chemokine CCL21 triggers LFA-1 adhesive properties on human dendritic cells	Eich, C.; Vries, I.J.M. de; Linssen, P.C.M.; Boer, A. de; Boezeman, J.B.M.; Figdor, C.G.; Cambi, A.
	2011	Targeted antigen delivery and activation of dendritic cells in vivo: steps towards cost effective vaccines	Tacken, P.J.; Figdor, C.G.
	2011	Interlaboratory round robin on cantilever calibration for AFM force spectroscopy.	Riet, J. te; Katan, A.J.; Rankl, C.; Stahl, S.W.; Buul, A.M. van; Phang, I.Y.; Gomez-Casado, A.; Schon, P.; Gerritsen, J.W.; Cambi, A.; Rowan, A.E.; Vancso, G.J.; Jonkheijm, P.; Huskens, J.; Oosterkamp, T.H.; Gaub, H.; Hinterdorfer, P.; Figdor, C.G.; Speller, S.
	2011	Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity.	Tacken, P.J.; Zeelenberg, I.S.; Cruz, L.J.; Hout-Kuijer, M.A. van; Glind, G. van de; Fokkink, R.G.; Lambeck, A.J.A.; Figdor, C.G.
	2011	Infection of dendritic cells with herpes simplex virus type 1 induces rapid degradation of CYTIP, thereby modulating adhesion and migration	Theodoridis, A.A.; Eich, C.; Figdor, C.G.; Steinkasserer, A.
	2011	Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation	Tacken, P.J.; Ginter, W.; Berod, L.; Cruz, L.J.; Joosten, B.H.G.M.; Sparwasser, T.; Figdor, C.G.; Cambi, A.
	2011	IL-4 and IL-13 alter plasmacytoid dendritic cell responsiveness to CpG DNA and herpes simplex virus-1	Tel, J.; Torensma, R.; Figdor, C.G.; Vries, I.J.M. de
	2011	DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells	Tel, J.; Benitez-Ribas, D.; Hoosemans, S.; Cambi, A.; Adema, G.J.; Figdor, C.G.; Tacken, P.J.; Vries, I.J.M. de
	2011	Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses	Vries, I.J.M. de; Tel, J.; Benitez-Ribas, D.; Torensma, R.; Figdor, C.G.
	2011	Antigen localization controls T cell-mediated tumor immunity	Zeelenberg, I.S.; Maren, W.W.C. van; Boissonnas, A.; van Hout-Kuijer, M.A.; Brok, M.H.M.G.M. den; Wagenaars, J.A.L.; van der Schaaf, A.; Jansen, E.J.S.; Amigorena, S.; Thery, C.; Figdor, C.G.; Adema, G.J.
	2011	The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells	Cruz, L.J.; Tacken, P.J.; Fokkink, R.; Figdor, C.G.
	2011	Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancer	Yigit, R.; Figdor, C.G.; Zusterzeel, P.L.M.; Pots, J.M.; Torensma, R.; Massuger, L.F.A.G.
	2011	Immune Adjuvant Efficacy of CpG Oligonucleotide in Cancer Treatment Is Founded Specifically upon TLR9 Function in Plasmacytoid Dendritic Cells	Nierkens, S.; Brok, M.H.M.G.M. den; Garcia, Z.; Togher, S.; Wagenaars, J.A.L.; Wassink, M.; Boon, L.; Ruers, T.J.M.; Figdor, C.G.; Schoenberger, S.P.; Adema, G.J.; Janssen, E.M.
	2011	Cytokine profiles in cyst fluids from ovarian tumors reflect immunosuppressive state of the tumor	Yigit, R.; Massuger, L.F.A.G.; Zusterzeel, P.L.M.; Pots, J.M.; Figdor, C.G.; Torensma, R.
	2011	Multimodal imaging of nanovaccine carriers targeted to human dendritic cells	Cruz, L.J.; Tacken, P.J.; Bonetto, F.J.; Buschow, S.I.; Croes, H.J.E.; Wijers-Rouw, M.J.P.; Vries, I.J.M. de; Figdor, C.G.
	2011	A novel (19)F agent for detection and quantification of human dendritic cells using magnetic resonance imaging	Bonetto, F.J.; Srinivas, M.; Heerschap, A.; Mailliard, R.; Ahrens, E.T.; Figdor, C.G.; Vries, I.J.M. de
	2011	Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice	Lesterhuis, W.J.; Punt, C.J.A.; Hato, S.V.; Eleveld-Trancikova, D.; Jansen, B.J.H.; Nierkens, S.; Schreibelt, G.; Boer, A. de; Herpen, C.M. van; Kaanders, J.H.A.M.; Krieken, J.H. van; Adema, G.J.; Figdor, C.G.; Vries, I.J.M. de
	2011	Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging	Aarntzen, E.H.J.G.; Srinivas, M.; Wilt, J.H. de; Jacobs, J.F.M.; Lesterhuis, W.J.; Windhorst, A.D.; Troost, E.G.C.; Bonenkamp, J.J.; Rossum, M.M. van; Blokx, W.A.M.; Mus, R.D.M.; Boerman, O.C.; Punt, C.J.A.; Figdor, C.G.; Oyen, W.J.G.; Vries, I.J.M. de
	2011	Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used	Lesterhuis, W.J.; Schreibelt, G.; Scharenborg, N.M.; Brouwer, H.M.; Gerritsen, M.J.P.; Croockewit, S.; Coulie, P.G.; Torensma, R.; Adema, G.J.; Figdor, C.G.; Vries, I.J.M. de; Punt, C.J.A.
	2011	Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients	Lesterhuis, W.J.; Vries, I.J.M. de; Schreibelt, G.; Lambeck, A.J.A.; Aarntzen, E.H.J.G.; Jacobs, J.F.M.; Scharenborg, N.M.; Rakt, M.W.M.M. van de; Boer, A.J. de; Croockewit, S.; Rossum, M.M. van; Mus, R.D.M.; Oyen, W.J.G.; Boerman, O.C.; Lucas, S.; Adema, G.J.; Punt, C.J.A.; Figdor, Carl
	2010	AFM topography and friction studies of hydrogen-bonded bilayers of functionalized alkanethiols	Riet, J. te; Smit, T.; Coenen, M.J.J.; Gerritsen, J.W.; Cambi, A.; Elemans, J.A.A.W.; Speller, S.E.; Figdor, C.G.
	2010	Molecular Friction as a Tool to Identify Functionalized Alkanethiols	Riet, J. te; Smit, T.; Gerritsen, J.W.; Cambi, A.; Elemans, J.A.A.W.; Figdor, C.G.; Speller, S.E.
	2010	Spatially resolved local intracellular chemical sensing using magnetic particles.	Shekhar, S.; Figdor, C.G.; Subramaniam, V.; Kanger, J.S.
	2010	Expression compilation of several putative cancer stem cell markers by primary ovarian carcinoma.	Di, J.; Yigit, R.; Figdor, C.G.; Duiveman-de Boer, T.; Massuger, L.F.A.G.; Torensma, R.
	2010	Dendritic cell subsets digested: RNA sensing makes the difference!	Buschow, S.I.; Figdor, C.G.
	2010	The role of tetraspanins in the pathogenesis of infectious diseases.	Spriel, A.B. van; Figdor, C.G.
	2010	Fungal pattern-recognition receptors and tetraspanins: partners on antigen-presenting cells.	Figdor, C.G.; Spriel, A.B. van
	2010	Molecular friction as a tool to identify functionalized alkanethiols.	Riet, J. te; Smit, T.; Gerritsen, J.W.; Cambi, A.; Elemans, J.A.; Figdor, C.G.; Speller, S.
	2010	The tetraspanin CD37 protects against glomerular IgA deposition and renal pathology.	Rops, A.L.; Figdor, C.G.; Schaaf, A. van der; Tamboer, W.P.M.; Bakker, M.; Berden, J.H.M.; Dijkman, H.B.P.M.; Steenbergen, E.J.; Vlag, J. van der; Spriel, A.B. van
	2010	(19)F MRI for quantitative in vivo cell tracking.	Srinivas, M.; Heerschap, A.; Ahrens, E.T.; Figdor, C.G.; Vries, I.J.M. de
	2010	Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen.	Tel, J.; Lambeck, A.J.A.; Cruz, L.J.; Tacken, P.J.; Vries, I.J.M. de; Figdor, C.G.
	2010	Dominant processes during human dendritic cell maturation revealed by integration of proteome and transcriptome at the pathway level.	Buschow, S.I.; Lasonder, E.; Deutekom, H.W. van; Oud, M.M.; Beltrame, L.; Huijnen, M.A.; Vries, I.J.M. de; Figdor, C.G.; Cavalieri, D.
	2010	Imaging of cellular therapies.	Srinivas, M.; Aarntzen, E.H.J.G.; Bulte, J.W.; Oyen, W.J.G.; Heerschap, A.; Vries, I.J.M. de; Figdor, C.G.
	2010	Hematopoietic stem cells are coordinated by the molecular cues of the endosteal niche.	Huurne, M.C. ter; Figdor, C.G.; Torensma, R.
	2010	Mesenchymal stem cells respond to TNF but do not produce TNF.	Berk, L.C.J. van den; Jansen, B.J.H.; Siebers-Vermeulen, K.G.C.; Roelofs, H.; Figdor, C.G.; Adema, G.J.; Torensma, R.
	2010	Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging.	Srinivas, M.; Cruz, L.J.; Bonetto, F.J.; Heerschap, A.; Figdor, C.G.; Vries, I.J.M. de
	2010	Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy.	Schreibelt, G.; Tel, J.; Sliepen, K.H.; Benitez-Ribas, D.; Figdor, C.G.; Adema, G.J.; Vries, I.J.M. de
	2010	Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro.	Cruz, L.J.; Tacken, P.J.; Fokkink, R.; Joosten, B.H.G.M.; Stuart, M.C.; Albericio, F.; Torensma, R.; Figdor, C.G.
	2010	Functional differences between mesenchymal stem cell populations are reflected by their transcriptome.	Jansen, B.J.H.; Gilissen, C.F.H.A.; Roelofs, H.; Oziemlak, A.M.; Veltman, J.A.; Raymakers, R.A.P.; Jansen, J.H.; Kogler, G.; Figdor, C.G.; Torensma, R.; Adema, G.J.
	2010	Immunogenicity of Dendritic Cells Pulsed with CEA Peptide or Transfected with CEA mRNA for Vaccination of Colorectal Cancer Patients.	Lesterhuis, W.J.; Vries, I.J.M. de; Schreibelt, G.; Schuurhuis, D.H.; Aarntzen, E.H.J.G.; Boer, A. de; Scharenborg, N.M.; Rakt, M.W.M.M. van de; Hesselink, E.J.; Figdor, C.G.; Adema, G.J.; Punt, C.J.A.
	2010	TLR4-mediated podosome loss discriminates gram-negative from gram-positive bacteria in their capacity to induce dendritic cell migration and maturation.	Helden, S.F.G. van; Dries, K. van den; Oud, M.M.; Raymakers, R.A.P.; Netea, M.G.; Leeuwen, F.N. van; Figdor, C.G.
	2010	Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma.	Hegmans, J.P.; Veltman, J.D.; Lambers, M.E.; Vries, I.J.M. de; Figdor, C.G.; Hendriks, R.W.; Hoogsteden, H.C.; Lambrecht, B.N.; Aerts, J.G.
	2010	Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells.	Schreibelt, G.; Benitez-Ribas, D.; Schuurhuis, D.; Lambeck, A.J.A.; Hout-Kuijer, M.A. van; Schaft, N.; Punt, C.J.A.; Figdor, C.G.; Adema, G.J.; Vries, I.J.M. de
	2010	A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients.	Lesterhuis, W.J.; Vries, I.J.M. de; Aarntzen, E.H.J.G.; Boer, A. de; Scharenborg, N.M.; Rakt, M.W.M.M. van de; Spronsen, D.J. van; Preijers, F.W.M.B.; Figdor, C.G.; Adema, G.J.; Punt, C.J.A.
	2010	DC-ATLAS : a systems biology resource to dissect receptor specific signal transduction in dendritic cells	Cavalieri, D.; Rivero, D.; Beltrame, L.; Buschow, S.I.; Calura, E.; Rizzetto, L.; Gessani, S.; Gauzzi, M.C.; Reith, W.; Baur, A.; Bonaiuti, R.; Brandizi, M.; Filippo, C. De; D'Oro, U.; Draghici, S.; Dunand-Sauthier, I.; Gatti, E.; Granucci, F.; Gundel, M.; Kramer, M.; Kuka, M.; Lanyi, A.; Melief, C.J.; Montfoort, N. van; Ostuni, R.; Pierre, P.; Popovici, R.; Rajnavolgyi, E.; Schierer, S.; Schuler, G.; Soumelis, V.; Splendiani, A.; Stefanini, I.; Torcia, M.G.; Zanoni, I.; Zollinger, R.; Figdor, C.G.; Austyn, J.M.
	2010	Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients.	Jacobs, J.F.M.; Punt, C.J.A.; Lesterhuis, W.J.; Sutmuller, R.P.M.; Brouwer, H.M.; Scharenborg, N.M.; Klasen, I.S.; Hilbrands, L.B.; Figdor, C.G.; Vries, I.J.M. de; Adema, G.J.
	2010	Ovarian cancer creates a suppressive microenvironment to escape immune elimination.	Yigit, R.; Massuger, L.F.A.G.; Figdor, C.G.; Torensma, R.
	2009	Dynamic re-organization of individual adhesion nanoclusters in living cells by ligand-patterned surfaces.	Diez-Ahedo, R.; Normanno, D.; Esteban, O.; Bakker, G.J.; Figdor, C.G.; Cambi, A.; Garcia-Parajo, M.F.

1 2 3 4 5 6 7 8 9 next